Company / Profit Margin
Eloxx Pharmaceuticals, Inc. Profit Margin History
FY2014-FY2016 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
-5062.4%
FY2016
5-year range
-78303.4% / -5062.4%
FY2014-FY2016
Trend
+93.5%
vs FY2015
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from -64792.6% to -5062.4% over the past 2 years.
Based on SEC 10-K filings.
-5062.4% in FY2016.
Improved from -64792.6% to -5062.4% over the past 2 years.
Profit Margin over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- In FY2016, profit margin increased 93.5% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -40.59 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2016 | -5062.4% | +93.5% |
| FY2015 | -78303.4% | -20.9% |
| FY2014 | -64792.6% | - |
As of FY2016 · SEC 10-K · Updated Jun 24, 2026